NCT00254007View on ClinicalTrials.gov

Depression and Traumatic Brain Injury

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

May 31, 2010

Conditions
DepressionTraumatic Brain Injury
Interventions
DRUG

citalopram (celexa)

20(1 tablet)-50(2 1/2 tablets) mg/day for a period of 6 or 10 weeks

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Ontario Mental Health Foundation

OTHER_GOV

lead

Sunnybrook Health Sciences Centre

OTHER

NCT00254007 - Depression and Traumatic Brain Injury | Biotech Hunter | Biotech Hunter